WO2023108250A1 - Plantes à production accrue d'acide gamma-linolénique - Google Patents
Plantes à production accrue d'acide gamma-linolénique Download PDFInfo
- Publication number
- WO2023108250A1 WO2023108250A1 PCT/CA2021/051827 CA2021051827W WO2023108250A1 WO 2023108250 A1 WO2023108250 A1 WO 2023108250A1 CA 2021051827 W CA2021051827 W CA 2021051827W WO 2023108250 A1 WO2023108250 A1 WO 2023108250A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- delta
- desaturase
- borage
- seed
- Prior art date
Links
- 235000020664 gamma-linolenic acid Nutrition 0.000 title claims abstract description 83
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 title claims abstract description 77
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 title claims abstract description 77
- 229960002733 gamolenic acid Drugs 0.000 title claims abstract description 77
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- 241000196324 Embryophyta Species 0.000 claims abstract description 101
- 241001072256 Boraginaceae Species 0.000 claims abstract description 72
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 claims abstract description 68
- 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 claims abstract description 59
- 108700028369 Alleles Proteins 0.000 claims abstract description 24
- 238000006467 substitution reaction Methods 0.000 claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 239000002773 nucleotide Substances 0.000 claims abstract description 17
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 17
- 108700026244 Open Reading Frames Proteins 0.000 claims abstract description 13
- 108091081024 Start codon Proteins 0.000 claims abstract description 10
- 230000000694 effects Effects 0.000 claims abstract description 9
- 235000007689 Borago officinalis Nutrition 0.000 claims description 55
- 150000007523 nucleic acids Chemical group 0.000 claims description 24
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 20
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 20
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 19
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- 229920001184 polypeptide Polymers 0.000 claims description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 108091033319 polynucleotide Proteins 0.000 claims description 10
- 102000040430 polynucleotide Human genes 0.000 claims description 10
- 239000002157 polynucleotide Substances 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 8
- 235000019198 oils Nutrition 0.000 claims description 8
- 235000021324 borage oil Nutrition 0.000 claims description 7
- 239000010474 borage seed oil Substances 0.000 claims description 5
- 238000003825 pressing Methods 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 description 15
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 6
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000002417 nutraceutical Substances 0.000 description 3
- 235000021436 nutraceutical agent Nutrition 0.000 description 3
- 238000009482 thermal adhesion granulation Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020001019 DNA Primers Proteins 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 102000019280 Pancreatic lipases Human genes 0.000 description 2
- 108050006759 Pancreatic lipases Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229940116369 pancreatic lipase Drugs 0.000 description 2
- 239000013615 primer Substances 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 241000218235 Cannabaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 208000033045 Premenstrual cramps Diseases 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 241000208476 Primulaceae Species 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- -1 Triacylglycerol fatty acid Chemical class 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009418 agronomic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/10—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits
- A01H1/101—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine or caffeine
- A01H1/104—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine or caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/10—Seeds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/06—Production of fats or fatty oils from raw materials by pressing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/19—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/19—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
- C12Y114/19003—Linoleoyl-CoA desaturase (1.14.19.3)
Definitions
- the present invention relates to plants, such as borage, with enhanced gamma linolenic acid (GLA) production.
- GLA gamma linolenic acid
- GLA gamma-linolenic acid
- GLA is an 18-carbon polyunsaturated fatty acid containing three double bonds, as shown in FIG. 1.
- GLA is biosynthesized in the metabolization of linolenic acid (LA) by the enzymatic activity of delta-6-desaturase. Delta-6-desaturase is highly conserved across plant species.
- GLA content in borage seed oil is typically well below 23% for most cultivated borage varieties.
- the variation in GLA content is believed to be due to multiple factors including genetics, geographical location, length of the light period during growing season, average temperature and diurnal temperature difference
- GLA is an essential fatty acid important for normal health functions and regulating metabolism. Due to its anti-inflammatory and antioxidant properties, borage oil containing GLA has been used to treat a wide range of both short- and long-term illnesses such as autoimmune disorders (e.g. multiple sclerosis), skin disorders, premenstrual syndrome and cramps, diabetic neuropathy, and other inflammatory conditions. Because of its health benefits, many nutraceutical supplements, functional foods and body care products are enriched with borage oil.
- Triacylglycerol fatty acid stereospecific positional distribution can affect the efficiency of fatty acid bio-absorption.
- GLA is known to be more bioavailable and bio-absorptive when present predominantly at the sn-2 position, rather than the sn-1 and sn-3 positions, of triacylglycerols.
- One aspect of the invention provides a plant or plant cell comprising a mutant allele at a gene locus for delta-6-desaturase, wherein the mutant allele produces delta-6- desaturase having increased activity resulting in increased gamma linolenic acid (GLA) production relative to a corresponding wild-type delta-6-desaturase, wherein the plant or plant cell produces seeds yielding an oil having a GLA content of greater than 25%, wherein the GLA content at the sn-2 position is at least 1 .45 times higher than the sum of the GLA content at the sn-1 and sn-3 positions.
- the plant may be borage and the plant cell may be a borage plant cell.
- Another aspect of the invention provides a plant, plant cell or seed comprising a mutant allele at a gene locus for delta-6-desaturase, wherein the mutant allele comprises a nucleic acid sequence: (i) with a sequence identity of at least 95% with SEQ ID NO:1 and/or (ii) comprising a G to T nucleotide substitution at the 852nd base pair from the start codon of the open reading frame of the delta-6-desaturase gene.
- the plant may be borage
- the plant cell may be a borage plant cell
- the seed may be a borage seed.
- Another aspect of the invention provides a plant, plant cell or seed comprising a mutant allele at a gene locus for delta-6-desaturase, wherein the mutant allele comprises an amino acid sequence: (i) with a sequence identity of at least 95% with SEQ ID NO:2 and/or (ii) an amino acid sequence comprising a Gin to His substitution at the 284th amino acid of the delta-6-desaturase enzyme.
- the plant may be borage
- the plant cell may be a borage plant cell
- the seed may be a borage seed.
- delta-6-desaturase enzyme comprising a nucleic acid sequence: (i) with a sequence identity of at least 95% with SEQ ID NO:1 and/or (ii) comprising a G to T nucleotide substitution at the 852nd base pair from the start codon of the open reading frame of the delta-6-desaturase gene.
- the delta-6-desaturase enzyme may be a borage delta-6-desaturase enzyme.
- delta-6-desaturase enzyme comprising an amino acid sequence: (i) with a sequence identity of at least 95% with SEQ ID NO:2 and/or (ii) comprising a Gin to His substitution at the 284th amino acid of the delta-6-desaturase enzyme.
- the delta-6-desaturase enzyme may be a borage delta-6-desaturase enzyme.
- Another aspect of the invention provides an isolated polynucleotide sequence encoding a polypeptide having delta-6-desaturase activity, wherein the polynucleotide comprises a nucleic acid sequence: (i) with a sequence identity of at least 95% with SEQ ID NO:1 or (ii) comprising a G to T nucleotide substitution at the 852nd base pair from the start codon of the open reading frame of the polynucleotide.
- Another aspect of the invention provides an isolated polypeptide sequence having delta-6-desaturase activity comprising an amino acid sequence: (i) with a sequence identity of at least 95% with SEQ ID NO:2 or (ii) comprising a Gin to His substitution at the 284th amino acid of the polypeptide.
- Another aspect of the invention provides a method of producing oil comprising: (a) crushing or pressing seeds of the plant of any one of claims 1 to 6; and (b) extracting the oil from the crushed or pressed seeds.
- Another aspect of the invention provides a method of producing a plant comprising crossing plants wherein at least one of the plants comprises a mutant allele at a gene locus for delta-6-desaturase, wherein the mutant allele comprises a nucleic acid sequence: (i) with a sequence identity of at least 95% with SEQ ID NO:1 and/or (ii) comprising a G to T nucleotide substitution at the 852nd base pair from the start codon of the open reading frame of the delta-6-desaturase gene.
- the plant may be borage.
- Another aspect of the invention provides a method of producing a plant comprising crossing plants wherein at least one of the plants comprises an amino acid sequence: (i) with a sequence identity of at least 95% with SEQ ID NO:2 and/or (ii) an amino acid sequence comprising a Gin to His substitution at the 284th amino acid of the delta-6- desaturase enzyme.
- the plant may be borage.
- Another aspect of the invention provides a use of the plant, plant cell or seed of any one of claims 1 to 6 to produce seed oil.
- the seed oil may be borage seed oil.
- Another aspect of the invention provides a use of an enzyme of as described herein, or a isolated polynucleotide as described herein, or an isolated polypeptide as described herein, to increase the GLA content in seed oil of a plant relative to a wild-type plant.
- the plant may be borage.
- Another aspect of the invention provides a seed oil comprising GLA content at the sn-2 position at least 1.45 times higher than the sum of the GLA content at the sn-1 and sn-3 positions.
- the seed oil may be borage seed oil
- FIG. 1 shows the chemical structure of gamma-linolenic acid (GLA).
- FIG. 2 shows the single nucleotide polymorphism (SNP) identified at the 852nd bp of the open reading frame of the delta-6-desaturase gene between low GLA and high GLA borage lines.
- the delta-6-desaturase DNA primers (D6-F and D6-R) are underlined.
- the nucleotides of the amplified delta-6-desaturase DNA sequence are in upper case letters.
- FIG. 3 shows the amino acid substitution identified at the 284 th amino acid of the delta-6-desaturase protein sequence between low GLA and high GLA borage lines.
- alleles refers to an alternative form of a nucleic acid sequence. Alleles result from a mutation, a change or an alternative reading of the genetic code. Any given gene may have none, one, or many allelic forms. Mutations which give rise to alleles include deletions, additions, or substitutions of nucleotides. Each of these changes may occur alone, or in combination with the others, one or more times in a given nucleic acid sequence.
- amino acid sequence refers to a peptide, a polypeptide, or a protein of either natural or synthetic origin.
- the amino acid sequence is not limited to the complete, endogenous amino acid sequence and may be a fragment, epitope, variant, or derivative of a protein expressed by a nucleic acid sequence.
- isolated polynucleotide sequence refers to a nucleic acid sequence that is no longer in its natural environment, for example in vitro or in a recombinant plant host cell.
- isolated polypeptide sequence refers to an amino acid sequence that is no longer in its natural environment, for example in vitro or in a recombinant plant host cell.
- naturally occurring refers to an endogenous polynucleotide or polypeptide that may be isolated from viruses or prokaryotic or eukaryotic cells.
- nucleic acid sequence refers to a DNA, cDNA or RNA molecule in single or double stranded form.
- recombinant nucleic acid refers to a nucleic acid sequence that is not naturally occurring or has a sequence that is made by an artificial combination of two or more otherwise separated segments of sequence. This artificial combination may be accomplished by chemical synthesis or artificial manipulation of isolated segments of nucleic acids, e.g., by conventional genetic engineering techniques.
- the term recombinant nucleic acid includes nucleic acids that have been altered solely by addition, substitution, or deletion of a portion of the nucleic acid sequence.
- a recombinant nucleic acid may include a nucleic acid sequence operably linked to a promoter sequence. Such a recombinant nucleic acid may be part of a vector, such as a viral vector that is used, for example, to transform a plant cell.
- Percentage sequence identities may determined by the Basic Local Alignment Search tool (BLASTTM) program set to default parameters available from the National Center for Biotechnology Information (NCBI), or by the CLUSTAL VTM algorithm as incorporated into the MEGALIGNTM sequence alignment program set to default parameters available as part of the LASERGENETM software package, a suite of molecular biological analysis programs (DNASTARTM, Madison WT).
- BLASTTM Basic Local Alignment Search tool
- NCBI National Center for Biotechnology Information
- CLUSTAL VTM as incorporated into the MEGALIGNTM sequence alignment program set to default parameters available as part of the LASERGENETM software package, a suite of molecular biological analysis programs (DNASTARTM, Madison WT).
- mutant alleles at the gene locus for delta-6- desaturase As described herein, plants containing such alleles can produce seed oil with higher GLA content and/or a greater proportion of GLA content at the sn-2 position, than wild-type varieties.
- the resulting high GLA content lines can be used for pharmaceutical, nutraceutical, and food purposes, for example.
- Plants referred to herein include borage, other members of Boraginaceae, as well as plants known to produce oil with relatively high GLA content including but not limited to plant species in families Ranunculaceae, Primulaceae, Cannabaceae (e.g. hemp), and Lamiaceae (e.g. perilla).
- Some embodiments relate to a single nucleotide polymorphism (SNP) of G to T at the 852 nd bp of the open reading frame of the delta-6-desaturase enzyme as shown in FIG. 2.
- SNP corresponds to a Gin to His substitution at the 284 th amino acid of the delta-6- desaturase enzyme as shown in FIG. 3.
- the SNP was identified through comparative genotypic analyses of high GLA and low GLA borage varieties and identifying markers of high GLA content. Trait stability was verified over multiple generations.
- Some embodiments relate to borage plants and parts thereof, the seed oil of which yields a GLA content of greater than wild-type borage plants, for example greater than 25%, and/or wherein the GLA content at the sn-2 position is higher than the sum of the GLA content at the sn-1 and sn-3 positions compared to wild-type borage plants, for example at least 1 .45 times higher than the sum of the GLA content at the sn-1 and sn-3 positions.
- Some embodiments relate to borage plants and seeds, in addition to those derived from cross-breeding as described in the examples herein, that are derived from mutations, recombinant variants and genetically engineered derivatives derived by conventional means which possess the enhanced GLA characteristics described herein. Some embodiments also extends to plant parts other than seeds, including plant cells, plant tissues and plant organs whether produced by plant tissue culture or otherwise.
- Some embodiments relate to nucleic acid sequences, including but not limited to isolated polynucleotides, coding a delta-6-desaturase enzyme having an identity of at least 60% with the sequence specified in SEQ ID NO 1 , in particular of at least 70%, preferably of at least 80% and particularly preferably of at least 90% and especially preferably of at least 95%.
- the delta-6-desaturase enzyme may be a borage delta-6-desaturase enzyme or a delta-6-desaturase enzyme of another plant species.
- Some embodiments relate to amino acid sequences, including but not limited to isolated polypeptides, coding a delta-6-desaturase enzyme having an identity of at least 60% with the sequence specified in SEQ ID NO 2, in particular of at least 70%, preferably of at least 80% and particularly preferably of at least 90% and especially preferably of at least 95%.
- the delta-6-desaturase enzyme may be a borage delta-6-desaturase enzyme or a delta-6-desaturase enzyme of another plant species.
- Some embodiments relate to crushing or pressing seeds of high GLA plants described herein to extract seed oil by using conventional methods to separate the seed oil from other seed constituents such as seed proteins and carbohydrates.
- the plant may be borage or another plant species.
- Some embodiments relate to using conventional transgenic and other conventional genetic engineering methods that use a recombinant nucleic acid including the sequence specified in SEQ ID NO 2 and/or a recombinant nucleic acid that codes for an amino acid sequence including the amino acid sequence specified in SEQ ID NO 3, to increase the GLA content in seed oil in a plant, such as borage plant.
- Some embodiments relate to producing plants having seed oil with high GLA content by crossing other plants with the high GLA borage plants described herein.
- Other plants may be wild-type plants or plants having seed oil with high GLA content, including but not limited to those described herein.
- the plants may be borage plants or other plant species.
- Some embodiments relate to a method of growing a crop comprising sowing seeds of high GLA plants described herein, and cultivating the seeds and resultant plant under suitable conditions to produce a crop.
- the crop may be a borage crop or crop of another plant species.
- Example 1 .0 - High GLA borage breeding [0047] 15,00 borage lines were grown from germplasm collections. After GLA screening with gas chromatography (GO), a few borage lines with GLA contents between 23.1% and 24.9% were determined, as shown in Table 1.
- GO gas chromatography
- Table 1 [0048] Those high GLA borage lines were used as female parents to cross with other good agronomic borage varieties or lines. Single plant pedigree selected through a large screening of offspring from those crosses in the F4 generation. High GLA plants with GLA content as high as 27.3% were found, as shown in Table 2.
- TAG Triacylglycerols
- TLC thin layer chromatography
- sn stereospecific numbering'
- the composition of fatty acid position at sn-2 of TAGs can be determined by incubating them with the enzyme pancreatic lipase in an appropriate buffer.
- the fatty acids are hydrolysed from the primary positions leaving a 2- monoacyl-sn-glycerol (2-MAG), which can be isolated by TLC for determination of its fatty acid composition.
- the samples for total lipids, TAG and 2-MAG were transmethylated with methanolic sulfuric acid and then analyzed with gas chromatography (GC).
- GLA content at the sn-2 position was found to be 1 .45 to 1.64 times higher than the sum of GLA at the sn-1 and sn-3 positions.
- the relatively high GLA at the sn- 2 position indicates the GLA in the oil of these high GLA borage lines are more bio-available and better absorbed when ingested.
- borage lines including 7 high GLA lines and 6 low GLA lines were selected for molecular marker development, as shown in Table 6.
- Low and high GLA borage genotypes were raised in the greenhouse under a 16 hour light (23 3) and 8 hour dark (1713) cycle. Young leaf tissues were collected an d stored in -8013 for further utilization.
- the total genomic DNA was extracted from the collected leaf tissues using DNeasyTM Plant mini kit (Qiagen, Germany) following the manufacturer’s protocol. Extracted DNA was utilized for further PCR application.
- GLA is synthesised by a D6-desaturase using linolenic as a substrate.
- the open reading frame of the borage D6-desaturase gene is 1344 base pairs long and it encodes 448 amino acids.
- a pair of primers were designed for DNA amplification of the borage delta-6-desaturase using PCR: (D6-F: 5'- TTTCATCAATGGCTGCTCAAAT-3’at 36 bp and D6-R: 5'- AAAGACAAGTTGCAATGACTCC-3' 22, at 1487 bp).
- the forward and reverse sequencing were performed with the Sanger sequencing platform. The beginning portion of the DNA sequence was resequenced with the IlluminaTM platform to ensure DNA sequencing was correct. Then the forward sequence and the reverse sequence were assembled. After the DNA sequences from all thirteen borage samples were assembled, the assembled sequences were aligned together.
- SNP single nucleotide polymorphism
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Environmental Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
La présente invention concerne une plante de bourrache ou une cellule végétale présentant un allèle mutant au niveau du locus du gène de la delta-6-désaturase. La plante ou la cellule végétale possède un allèle mutant produisant une delta-6-désaturase à activité accrue entraînant une production accrue d'acide gamma-linolénique (AGL) par comparaison avec une delta-6-désaturase de type sauvage correspondante. L'allèle mutant est caractérisé par une substitution de nucléotides G à T au niveau de la 852e paire de bases à partir du codon de départ du cadre de lecture ouvert du gène de la delta-6-désaturase. La plante ou la cellule végétale produit des graines donnant une huile possédant une teneur en AGL supérieure à 25 %, la teneur en AGL en position sn-2 étant au moins 1,45 fois supérieure à la somme des teneurs en AGL en positions sn-1 et sn-3.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2021/051827 WO2023108250A1 (fr) | 2021-12-16 | 2021-12-16 | Plantes à production accrue d'acide gamma-linolénique |
GBGB2409759.4A GB202409759D0 (en) | 2021-12-16 | 2021-12-16 | Plants with enhanced gamma linolenic acid production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2021/051827 WO2023108250A1 (fr) | 2021-12-16 | 2021-12-16 | Plantes à production accrue d'acide gamma-linolénique |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023108250A1 true WO2023108250A1 (fr) | 2023-06-22 |
Family
ID=86775191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2021/051827 WO2023108250A1 (fr) | 2021-12-16 | 2021-12-16 | Plantes à production accrue d'acide gamma-linolénique |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202409759D0 (fr) |
WO (1) | WO2023108250A1 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614393A (en) * | 1991-10-10 | 1997-03-25 | Rhone-Poulenc Agrochimie | Production of γ-linolenic acid by a Δ6-desaturase |
-
2021
- 2021-12-16 GB GBGB2409759.4A patent/GB202409759D0/en active Pending
- 2021-12-16 WO PCT/CA2021/051827 patent/WO2023108250A1/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614393A (en) * | 1991-10-10 | 1997-03-25 | Rhone-Poulenc Agrochimie | Production of γ-linolenic acid by a Δ6-desaturase |
Non-Patent Citations (4)
Title |
---|
HOEY C-E, MICHAEL SOEBERG CHRISTENSEN: "ABSORPTION OF GAMMA-LINOLENIC ACID FROM BORAGE, EVENING PRIMROSE, AN BLACK CURRANT SEED OILS: FATTY ACID PROFILES, TRIACYLGLYCEROL STRUCTURES, AND CLEARANCE RATES OF CHYLOMICRONS IN THE RAT", PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM OF GLA, XX, XX, 1 January 1996 (1996-01-01), XX , pages 54 - 65, XP009035802 * |
QIU, X ET AL.: "Expression of borage DELTA6 desaturase in Saccharomyces cerevisiae and oilseed crops", CANADIAN JOURNAL OF BOTANY, vol. 80, 2002, pages 42 - 49, XP009123317, ISSN: 0008-4026 * |
SAYANOVA, O ET AL.: "Expression of a borage desaturase cDNA containing an N-terminal cytochrome bs domain results in the accumulation of high levels ofDELTA6-desaturated fatty acids in transgenic tobacco", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 94, April 1997 (1997-04-01), pages 4211 - 4216, XP002099447, ISSN: 0027-8424, DOI: 10.1073/pnas.94.8.4211 * |
SENANAYAKE, SPJN ET AL.: "Positional distribution of FA in TAG of enzymatically modified borage and evening primrose oils", LIPIDS, vol. 37, August 2002 (2002-08-01), pages 803 - 810, XP008034095, ISSN: 0024-4201, DOI: 10.1007/s11745-002-0964-5 * |
Also Published As
Publication number | Publication date |
---|---|
GB202409759D0 (en) | 2024-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1656449B1 (fr) | Desaturases des acides gras issues de primula | |
EA030862B1 (ru) | Растение brassica, содержащее мутантные аллели (жирный ацил)-acp-тиоэстеразы | |
US11234389B2 (en) | Nucleotide sequences mutated by insertion that encode a truncated oleate desaturase protein, proteins, methods and uses | |
RU2008141698A (ru) | Fad-2-мутанты и растения с высоким содержанием олеиновой кислоты | |
US7423198B2 (en) | High oleic acid Brassica juncea | |
US10865421B2 (en) | Acyltransferases and methods of using | |
US20200370062A1 (en) | Plants having increased oil quality | |
US20200308596A1 (en) | Plants having increased oil quality | |
WO2019223722A1 (fr) | Application de gène sdg40 ou sa protéine codée | |
Razeghi-Jahromi et al. | Sequence characterization and temporal expression analysis of different SADs and FAD2-2 genes in two Iranian olive cultivars | |
CN113423837B (zh) | 产生提高的水平的多不饱和脂肪酸的芸苔属植物 | |
WO2023108250A1 (fr) | Plantes à production accrue d'acide gamma-linolénique | |
Chen et al. | Whole-genome and genome-wide association studies improve key agricultural traits of safflower for industrial and medicinal use | |
US20230235347A1 (en) | Improved Camelina Plants and Plant Oil, and Uses Thereof | |
US20220346340A1 (en) | Brassica juncea Line NUBJ1207 | |
CN101906154B (zh) | 调节植物叶片转绿过程的蛋白、其编码基因及应用 | |
US20190045735A1 (en) | High alpha linolenic acid flax | |
AU2004203364B2 (en) | High oleic acid brassica juncea | |
IL207969A (en) | A procedure for producing tomato implants with durable properties | |
WO2023196865A2 (fr) | Procédés et compositions pour produire des plantes ayant des taux élevés d'acides gras végétatifs | |
CN102242112B (zh) | 具有OsMS2基因的载体的应用 | |
Camacho-Roger | Molecular Markers and Genes Associated with Low Palmitic and Low Linolenic acid Content in N97-3681-11 and N97-3708-13 Soybean Lines. | |
AU2002301539B2 (en) | Fatty acid desaturases and mutant sequences thereof | |
Watts | Development of Linkage Map of Brassica juncea using molecular markers and detection of Quantitative Trait Loci for oil content, seed protein and fatty acids | |
CA2471884A1 (fr) | Brassica juncea a forte teneur en acide oleique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21967450 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 812084 Country of ref document: NZ |
|
NENP | Non-entry into the national phase |
Ref country code: DE |